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Abstract
TMEM45A gene encodes an initially uncharacterized predicted transmembrane protein.
We previously showed that this gene is highly expressed in keratinocytes where its expres-
sion correlates with keratinization, suggesting a role in normal epidermal physiology. To
test this hypothesis, we generated TMEM45A knockout mice and found that these mice
develop without any evident phenotype. The morphology of the epidermis assessed by his-
tology and by labelling differentiation markers in immunofluorescence was not altered. Tolu-
idine blue permeability assay showed that the epidermal barrier develops normally during
embryonic development. We also showed that depletion of TMEM45A in human keratino-
cytes does not alter their potential to form in vitro 3D-reconstructed epidermis. Indeed, epi-
dermis with normal morphogenesis were generated from TMEM45A-silenced
keratinocytes. Their expression of differentiation markers quantified by RT-qPCR and evi-
denced by immunofluorescence labelling as well as their barrier function estimated by Luci-
fer yellow permeability were similar to the control epidermis. In summary, TMEM45A gene
expression is dispensable for epidermal morphogenesis, keratinization and barrier forma-
tion. If this protein plays a role in the epidermis, its experimental depletion can possibly be
compensated by other proteins in the two experimental models analyzed in this study.
Introduction
The main function of the epidermis is to maintain an efficient barrier between the organism
and its external environment. Keratinocyte is the main cell type in the epidermis. These cells
undergo proliferation and terminal differentiation, producing the cornified layer, the outer-
most skin barrier. This layer is composed of dead keratinocytes in which the intracellular con-
tent has been replaced by a compact keratin network, and the plasma membrane internally
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reinforced by a rigid proteolipidic cornified envelope. The intercellular spaces are filled by a
mostly lipidic “mortar” that participates to the impermeability of the barrier [1–3]. The com-
plex process responsible for epidermal barrier maintenance is called keratinization.
Although morphological modifications of keratinocytes during keratinization have been
well characterized, the precise molecular and cellular functions of many actors of this process
remain largely unknown. We showed recently that expression of TMEM45A (also known as
DERP7, DNAPTP4 and FLJ10134) is strongly induced by differentiation in cultured human
keratinocytes and correlates with keratinization in the granular layer of the epidermis. We also
observed the same correlation in thymic keratinized epithelial cells inside Hassal bodies [4].
High-throughput RNA expression analyses similarly associated TMEM45A expression with
skin and keratinization in human and mouse [5–8]. In addition, Tmem45a was identified as a
candidate for positive regulation of embryonic epidermal growth [9]. Altogether, these obser-
vations suggested a role for TMEM45A in epidermal development and maintenance. However,
the nature of this possible role remained completely unknown.
TMEM45A belongs to the large group of TMEM genes encoding uncharacterized proteins
predicted to contain transmembrane (TM) domains. Human TMEM45A and mouse Tmem45a
orthologs encode proteins sharing 64% of identical amino acids. We observed that TMEM45A
protein is mainly located in the trans-golgi network (TGN) in cultured human keratinocytes
and in the granular layer of epidermis [4]. No TMEM45A was observed in lysosomes or in cor-
neodesmosin-containing lamellar bodies [4]. One important function of granular keratinocytes
is secretion of lamellar bodies (LB) content, including precursors of the intercorneocyte matrix
and their processing enzymes, enzymes involved in desquamation (and their inhibitors), anti-
microbial peptides, and corneodesmosin, a protein that reinforces desmosomes [10]. The gran-
ular keratinocyte is thus a specialized secretory cell, whose LB are the only clearly identified
secretion vesicles [10]. Endomembrane system and the associated secretion vesicles present in
granular keratinocytes are complex and only partially characterized. Apical membrane of these
cells exhibits many deep invaginations connecting together intercellular space, lamellar bodies
and trans-golgi network [11]. Lipids are hypothesized to be transported into the Golgi appara-
tus and LB by membrane transporters, and then processed inside the Golgi apparatus [12, 13].
TGN and LB are proposed to be heterogeneous compartments in granular keratinocytes, as
some cargoes are independently synthetized and transported as separated aggregates [14, 15].
In order to unveil a role for TMEM45A in epidermis, we generated KO mice. To the best of
our knowledge, this is the first time that such KO mice are reported. Furthermore, we invali-
dated TMEM45A expression in 3D-reconstructed human epidermis and in autocrine mono-
layer cultures of human keratinocytes.
Materials and Methods
Antibodies and chemicals
Antibodies and chemicals are described in supplementary data (S1 File).
Generation of Tmem45a knockout mice
The Tmem45a targeting vector PG00253_Z_5_A04 was obtained from the International
Mouse Phenotyping Consortium (IMPC). Homologous recombination of this vector in ES
cells produced a conditional “knockout first” allele with a PGK-neomycin cassette and a LacZ
reporter gene are inserted between the second and the third Tmem45a exons (Tmem45atm1a
(KOMP)Mbp allele, Fig 1A). The targeting vector was introduced by electroporation in 129/Ola
embryonic stem cells (ES14Tg2a). Gene replacement was detected by PCR (Primer-Forward:
5’-AGATGGCGCAACGCAATTAAT-3’; Primer-Reverse: 5’-
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GGAATAACCCAGAGGTCCAT-3’). Integrity of the recombined Tmem45a allele was verified
by Southern blot analyses (BamHI digestion) using probes corresponding to nucleotides 56764
to 57475 (NC_000082.6) and to LacZ sequences (data not shown). Embryonic stem cells con-
taining the recombined allele were injected into C57BL/6 blastocysts and reimplanted into
CD1 pseudopregnant females. One chimeric male bearing the recombined allele was mated
with C57BL/6 female mice to obtain heterozygotes Tmem45atm1a(KOMP)Mbp.
These mice were mated with PGK-Cre transgenic mice to obtain animals with allele Tme-
m45atm1b(KOMP)Mbp, with deleted PGK-Neo and Tmem45a exons 3 and 4 (Fig 1A). Homozy-
gous Tmem45atm1b(KOMP)Mbp males and females were obtained by subsequent crossings.
All mice used in this work have a mixed 129/Ola and C57BL/6 genetic background. The
approval of the local Ethic committee of the University of Namur was obtained for all the
experiments, which were performed according to the European legislation.
Mouse genotyping
Genotyping of animals was performed by PCR using DNA extracted from tails. The WT
Tmem45a allele was amplified by PCR1 (PCR1_F primer: GTTCTACAACCACACACACG
and PCR1_R primer: CTGAGTTATTCTAGGCAGGG) and gives a 758 bp fragment. Tme-
m45atm1b(KOMP)Mbp allele was amplified by PCR2 (using PCR2_F primer: TCACCCGAGTGT-
GATCATCT and PCR2_R primer: GGTAGTTCAGGCAGTTCAA). Amplified fragment
length from the HET or KO mouse is 691 bp (Fig 1B).
Isolation of normal human epidermal keratinocytes
Normal human adult abdominal skin was obtained from plastic surgery of healthy subjects
who had given their informed consent. They were processed to isolate primary keratinocytes,
as described in [16].
Fig 1. Gene targeting of Tmem45a by homologous recombination in embryonic stem cells. (A)
Schematic representation of the WT Tmem45a allele, of the targeting vector, of the knockout first allele and
allele obtained after Cre-mediated recombination. (B) Tmem45a knockout mice genotyping. PCR1 amplified
theWT allele and PCR2 is specific of the targeted allele.
doi:10.1371/journal.pone.0147069.g001
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Lentiviral particles
MISSION pLKO.1-puro vector—based lentiviral particles containing a shRNA cassette under
the U6 promoter and a puromycin resistance gene were produced by Sigma-Aldrich (St Louis,
MO, US). The shRNA targeting TMEM45A exon 4 (TMEM45A shRNA; sequence 5’-
GAGTTCCTTGTTCGGAACAAT-3’; nucleotide position 821–841 on the mRNA sequence
(NCBI Reference: NM_018004.1)) was chosen. As negative control, a non-target shRNA that
does not target any known mammalian gene (NT shRNA; 5’-CCGGCAACAAGATGAAGAG-
CACCAACTC-3’) was used.
Human keratinocyte transduction
Secondary cultures of keratinocytes were trypsinized, as described in [16] and the pellet was
resuspended in growth medium containing 4 μg/ml protamine sulfate to increase infection effi-
ciency. Lentiviral particles containing non-target shRNA (NT shRNA) or shRNA targeting
TMEM45A (TMEM45A shRNA) were added to the cell suspension at a multiplicity of infec-
tion (MOI) of 10. Cells were seeded at a density of 7,000 cells/cm2. 24 hours post-infection,
transduced cells were selected in medium containing 2 μg/ml puromycin.
Reconstruction of human epidermis from transduced keratinocytes
When keratinocytes cultures transduced with NT or TMEM45A shRNA covered 80% of the
flask area, cells were trypsinized and used to generate reconstructed human epidermis on poly-
carbonate filter, as described in [17], except that 250,000 transduced keratinocytes were seeded
per insert. Reconstructed epidermis were processed for histology, as described in [17].
Confluence-induced differentiation of autocrine transduced monolayers
of human keratinocytes
When keratinocyte cultures reached 50–60% of cell coverage on the substratum, medium was
replaced by fresh medium for autocrine growth. Confluent cultures stop to proliferate and
begin to differentiate, as shown by the expression of differentiation markers [16].
RT-qPCR
Total RNA was isolated using High Pure RNA isolation kit (Roche, Basel, Switzerland) for
monolayers and RNeasy mini kit (Qiagen, Hilden, Germany) for reconstructed human epider-
mis and mouse tissues, according to manufacturer’s instructions. 1 μg of total RNA was reverse
transcribed using SuperScript II kit (Life Technologies, Carlsbad, CA), according to the manu-
facturer’s instructions. PCR assays contained 300 nM of primers and FastStart Universal SYBR
Green Master (Rox) (Roche, Basel, Switzerland). mRNA expression levels were quantified
using the threshold cycle method on a 7300 real-time PCR system from ABI (Life Technolo-
gies, Carlsbad, CA) and normalized to the geometric mean of RPLP0 and TBP reference genes
values [16]. Primer sequences for human and mouse genes and for the puromycin resistance
gene are described in supplementary data (S1 File).
Independent experiments were performed in triplicates. Values were expressed as relative
quantification level with error bars representing 95% confidence intervals. Data were analyzed
by paired t-test or two-way analysis of variance.
TMEM45A in Epidermal Physiology
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Immunofluorescence detection in keratinocytes, reconstructed human
epidermis and tissues
Immunofluorescence detection is described in supplementary data (S1 File).
Transmission Electron Microscopy
Punches of 3 mm diameter from reconstructed human epidermis were fixed in 2.5% glutaral-
dehyde-formaldehyde buffer (0.1 M sodium cacodylate pH 7.4) overnight at 4°C and then
washed with 0.2 M Sorensen phosphate buffer. Samples were post-fixed with 1% OsO4 in
buffer containing 0.05 M phosphate buffer (Sorensen buffer dilution 1:4) and 0.25 M glucose
for one hour at room temperature. Punches were dehydrated in ascending ethanol series up to
ethanol 100% and incubated with propylene oxide. They were then progressively embedded in
ascending propylene oxide/epoxy resin series (Araldite 502/Embed 812). After polymerization,
ultrathin sections were mounted on grids and post-stained with uranyl acetate and lead citrate.
Tissues were observed and pictured under a TECNAI 10 transmission electron microscope
(FEI, OR).
Western blot analysis of mouse tissues
Protein extraction from specific organs was performed after immerging organs in lysis buffer
(20 mMMES, 30 mM Tris, 100 mMNaCl, 1% Triton X100, 20 mMNEM) containing a prote-
ase inhibitor mixture (cOmplete from Roche Molecular Biochemicals, dilution 1:25) and phos-
phatase inhibitors (1 mM NaVO3, 10 mM p-nitrophenyl phosphate, 10 mM β-
glycerophosphate and 5 mMNaF) on ice. After centrifugation for 10 min at 13,000 rpm and
4°C, a Pierce protein quantification was performed. 5x loading buffer (0.5 M Tris-HCl pH 6.8,
20% SDS; 2-β-mercapoethanol, 30% glycerol, bromophenol blue) was added to the samples.
Then samples were heated at 37°C for 3 min before analysis by electrophoresis performed on
10% polyacrylamide gel (Bio-Rad, Hercules, CA, US). Proteins were transferred onto PVDF
membranes, blocked for 1 hour at room temperature with blocking solution (LI-COR, Lincoln,
NE). Anti-TMEM45A was used as primary antibody and incubated O/N at 4°C. After washing
in PBS- 0.1% Tween, the membrane was incubated with anti-rabbit IRDye-labelled antibody
for 1 hour at RT. After washing, the membrane was scanned using an Odyssey infrared imag-
ing system (LI-COR, Lincoln, NE). β-actin was used as loading control.
Western blot analysis of human cultured keratinocyte monolayers
Human keratinocyte cultured as monolayers were lyzed with 0.05 M Hepes pH 7.4, 0.15 M
NaCl, 0.1% SDS, 1% NP40, 1% Triton 1%, PIC (cOmplete from Roche Molecular Biochemicals,
dilution 1:25) and PIB (1 mM NaVO3, 10 mM p-nitrophenyl phosphate, 10 mM β-glyceropho-
sphate and 5 mMNaF). After Pierce protein quantification, WB was performed according to
standard protocols, except that samples were not boiled before loading, but incubated 3 min-
utes à 37°C. Indeed, like TMEM45B [18], TMEM45A shows thermal aggregation in SDS—
PAGE gels when samples are heated at 100°C.
In situ staining of β-galactosidase activity in mouse tissues
Tail skin and other tissues were obtained from euthanized mice. Tissues were rinsed in PBS
and fixed 30 min on ice in a solution containing 0.2% glutaraldehyde, 5 mM EGTA and 2 mM
MgCl2 diluted in 0.1 M phosphate buffer pH 7.3. Tissues were washed 3 times during 15 min
in washing buffer containing 0.02% NP-40, 0.01% sodium deoxycholate and 2 mMMgCl2
diluted in 0.1 M phosphate buffer pH 7.3. Tissue samples were stained in a solution containing
TMEM45A in Epidermal Physiology
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0.02% NP-40, 0.01% sodium deoxycholate, 2 mMMgCl2, 5 mM potassium ferricyanide diluted
in 0.1 M phosphate buffer pH 7.3 with 1 mg/ml of X-gal diluted in N,N-dimethylformamide
during 16 hours. Then, tissues were washed with PBS and fixed during 8 hours with 4% PFA.
They were embedded in paraffin, and processed for histology. After coloration with Hemalun
Erythrosin Safran, tissues were observed under an Olympus AX70 microscope (Tokyo, Japan).
Toluidine blue exclusion
Tmem45a+/- females were bred with Tmem45a+/- males. 16.5 days post-coïtum, females were
euthanized and embryos collected. Embryos or neonatal mice were euthanized on ice. Tails
were kept for genotyping. Embryos were washed successfully in increased methanol baths
(25%, 50%, 75% and finally 100%) and decreased methanol baths during 1 min each before
staining for 30 min in 0.1% of toluidine blue diluted in PBS. Then, embryos were washed twice
with PBS and fixed in 4% formalin-acetic acid solution.
Permeability of reconstructed epidermis to Lucifer Yellow
Inserts were incubated in a 24 wells-plate containing 200 μl of growth medium per well. A 1
mM Lucifer Yellow solution was prepared in culture growth medium. After filtration, 150 μl of
the Lucifer Yellow solution was added on top of each culture. After 6 hours of incubation in
darkness, reconstructed epidermis were washed three times with PBS, fixed and processed as
described [17]. Fluorescence of LY was observed under an AX70 Olympus microscope (Tokyo,
Japan). Quantification of the Lucifer Yellow fluorescence contained in medium under the tissue
was performed using Fluoriscan ASCENT spectrofluorimeter (Thermo scientific, MA) (excita-
tion 485 nm; emission 535 nm).
pHmeasurement
pH at the surface of the cornified layer was measured using a skin dedicated pH meter (Skin-
pH-Meter PH 905, Courage+Khazaka Electronic GmbH, Köln, Germany).
Results
Invalidation of TMEM45A in mouse and human keratinocytes does not
disturb epidermal development and maintenance
To determine whether Tmem45a is required for epidermal development or homeostasis, we
generated for the first time Tmem45a knockout mice. Mice harboring a “knockout first” condi-
tional (floxed) LacZ-tagged Tmem45a allele (Tmem45atm1a(KOMP)Mbp) were generated using a
targeting vector developed by the International Mouse Phenotyping Consortium (IMPC) (Fig
1). In this allele, the splice acceptor of the LacZ cassette captures the RNA transcript and an
efficient polyadenylation signal truncates the transcripts so that the part of the gene down-
stream from the cassette (exons 3 to 5) is not transcribed into mRNA. This allele only has the
potential to encode a peptide corresponding to the first 63 aa of Tmem45A encoded by exon 2
(exon 1 is not coding). The LacZ present in this allele reports transcriptional activity of the
TMEM45A promoter. As exons 3 and 4 are flanked by LoxP sites, crossing with PGK-Cre del-
eter mice allowed us to generate mice with deleted exons 3 and 4 (Tmem45atm1b(KOMP)Mbp
allele, noted Tmem45a- hereafter). This allele is a null allele because the deletion results in a
frameshift in exon 5 that should result in non-sense mediated decay.
Tmem45a+/- heterozygous mice were viable and fertile. Interbreeding of these mice pro-
duced pups with normal mendelian ratio, including 25% of homozygous Tmem45a-/- mice.
Gross morphological and histopathological features of these knockout mice were normal,
TMEM45A in Epidermal Physiology
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including the epidermis (data not shown). Weight gain was not different from wild-type
littermates.
RT-qPCR proved that the residual level of Tmem45amRNA was reduced to background in
all tested organs (Fig 2A) as well as in several anatomical location of skin (ear, tail, belly and
back, data not shown), indicating that, in case a truncated TMEM45A protein is produced, its
level could only be very low. The possible expression of a truncated protein could not be inves-
tigated because the only available TMEM45A antibody recognizes a peptide located in the C-
terminal part of the protein, which is missing in the knockout animals. The 31 kDa band
detected by Western blot analysis of TMEM45A in skin of wild type mouse was absent in
Tmem45a-/- skin (Fig 2B), confirming the absence of Tmem45a in the KO mice.
We used the LacZ reporter to investigate the activity of the Tmem45a promoter (and thus
the putative expression of Tmem45amRNA) in mouse tissues by in situ X-gal staining of β-
galactosidase activity (Fig 2C). X-gal staining was observed in the suprabasal epidermal layers,
hair follicles, sebaceous glands and thymic Hassal bodies. Similar staining patterns were
observed in Tmem45atm1a(KOMP)Mbp heterozygotes and homozygous mice. As expected, no
LacZ staining was observed in wild type control mice.
A direct detection of the TMEM45A protein was performed by immunofluorescence label-
ling on skin sections from the tail (the same anatomical location than in Fig 2C). These results
showed that TMEM45A is expressed in the suprabasal layers of the epidermis of WT mice but
not in the epidermis of the KO mice (Fig 2D). Furthermore, the labelling was granular, which
is consistent with the subcellular localization of the protein in the Golgi apparatus. Finally, we
also isolated mouse embryonic fibroblasts (MEFs) from three different pairs of WT and KO lit-
termates and the expression of TMEM45A protein was detected by immunofluorescence label-
ling. The protein was only detected in WTMEFs incubated under hypoxia. These results are
consistent with the fact that TMEM45A is highly expressed in skin but not in other tissues (the
protein was not detected in normoxic MEFs) but that its expression is induced by hypoxia [19].
Again, the fluorescence labelling was granular and localized on one side of the nucleus, which
is consistent with a Golgi apparatus location (S1 Fig). On the other hand, no labelling was
observed in KOMEFs, even under hypoxia conditions.
We used another experimental model to investigate the possible role of TMEM45A in kera-
tinocyte differentiation: reconstructed human epidermis (RHE), a simplified epidermal tissue
obtained in vitro after culture of human keratinocytes on polycarbonate filters [17].
We invalidated TMEM45A in human epidermal keratinocytes by transduction of lentiviral
particles designed to express shRNA targeting TMEM45A. RT-qPCR andWestern blot analysis
showed that TMEM45AmRNA and protein were actually depleted in transduced cells (Fig 3).
We observed that TMEM45A-invalidated keratinocytes were able to generate RHE exhibiting
normal morphology under optical and electron microscopy (Figs 3B and 4). TMEM45A-
depleted keratinocytes were also cultured in autocrine monolayers and induced to differentiate
by cell confluence (Fig 3D–3F). The mRNA relative expression of early (KRT10) and late
(TGM1, FLG and LOR) markers of differentiation was assessed at sub-confluence, confluence
and post-confluence stages. No significant alteration was observed, except for TGM1, but a
decreased mRNA level for all markers was noticed in TMEM45A-deficient cultures (Fig 5).
Keratinization of TMEM45A-invalidated RHE was also monitored by measuring expression of
genes involved in differentiation (KRT14, KRT10, FLG, LOR, IVL, TGM1, FLG, SPINK5 and
LCE1B). The relative mRNA levels of these genes were found unaltered (Fig 6A). In situ detec-
tion by immunofluorescence labelling of keratin-14, keratin-10, involucrin and filaggrin fur-
ther indicated that TMEM45A invalidation did not modify the histological localization of these
proteins (Fig 6B). Similarly, no alteration of keratin 14, keratin 10 or loricrin was observed in
TMEM45A in Epidermal Physiology
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the epidermis of Tmem45a-/- mice (Fig 6C). Together, these observations indicate that
TMEM45A is not required for epidermal differentiation and keratinization.
The epidermal barrier function is not altered by TMEM45A deficiency
Despite the normal expression of epidermal differentiation/keratinization markers, the epider-
mal barrier function could be disturbed in the absence of TMEM45A. We tested this function
both in Tmem45a knockout mice and in TMEM45A-depleted RHE. Tmem45a knockout mice
develop normally and are viable, excluding a severe barrier defect at birth or later. We investi-
gated the establishing of barrier formation during development, using the toluidine blue
whole-mount permeability assay [20]. No difference was observed between wild type, and
Fig 2. Absence of expression of Tmem45a in the Tmem45a-/- mouse. (A)Quantification by RT-qPCR of
Tmem45amRNA level in different organs from wild type (WT) and knockout (KO) mice. The RNA levels are
represented in arbitrary units, with a value of 1.00 corresponding to the level in WT skin. (B)Western blot
analysis of TMEM45A abundance in tissues from wild type (WT) and Tmem45a knockout (KO) adult mice. β-
actin was used as the loading control. Different organs and different skin anatomical location were analyzed
in the two western blots. “CTL+” corresponds to a protein extract of HEK293 cells transfected with a plasmid
encoding the human TMEM45A cDNA. (C) X-gal staining of the LacZ reporter activity in tail skin and thymus
tissues of WT, Tmem45+/- (HET) and Tmem45-/- (KO) mice. Tissues were also stained with Hemalun
Erythrosin (HE). Arrows indicate Hassal bodies. Scale bars: 50 μm. (D) Immunofluorescence detection of
TMEM45A in tail skin of WT and KOmice. Scale bars: 50 μm. (B, C, D). The presented data are
representative of the results obtained for at least three independent experiments.
doi:10.1371/journal.pone.0147069.g002
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Fig 3. Efficient invalidation of TMEM45A in RHE after 11 days of reconstruction (A-C) and in
monolayer culture of human keratinocytes (D-F). (A) Relative quantification of TMEM45AmRNA levels in
epidermis reconstructed with keratinocytes transduced with NT shRNA or shRNA targeting TMEM45A. Bars
represent 95% confidence intervals. Paired t-test (n = 3, **p0.1). (B)Morphology of HE-stained epidermis.
Bars: 50 μm. (C) Immunofluorescence detection of TMEM45A in RHE. Bars: 50 μm. (D) Relative mRNA
quantification in monolayers at subconfluence (SC), confluence (C) and post-confluence (PC). Bars
represent 95% confidence intervals. ANOVA 2 (n = 3, *** p0.001). (E) TMEM45A abundance analysis by
WB in post-confluent monolayer culture. RPL13a is the loading control. (F) Detection of TMEM45A in
confluent monolayers culture. Bars: 25 μm. (B, C, E, F). The presented data are representative of the results
obtained for at least three independent experiments.
doi:10.1371/journal.pone.0147069.g003
Fig 4. TMEM45A-silencing has no obvious impact on the morphology of human reconstructed
epidermis in transmission electronmicroscopy. Reconstructed epidermis from keratinocytes transduced
with NT or TMEM45A shRNA after 11 days of reconstruction were processed for transmission electron
microscopy. SC: stratum corneum. SG: stratum granulosum. SS: stratum spinosum. SB: stratum basale. F:
filter. The dotted lines delineate the border between SS and SG.
doi:10.1371/journal.pone.0147069.g004
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Fig 5. TMEM45A invalidation does not alter confluence-induced differentiation of keratinocytes.
Relative quantification of KRT10, TGM1, FLG and LORmRNA expression levels was performed after RNA
extraction from human keratinocytes grown as autocrine monolayers after being transduced with NT or
TMEM45A shRNA at subconfluence (SC), confluence (C) and post-confluence (PC) of the culture. Bars
represent 95% confidence intervals. ANOVA 2 (n = 3, *** p0.001).
doi:10.1371/journal.pone.0147069.g005
Fig 6. TMEM45A expression is not essential for keratinization. (A) Relative quantification of KRT14,
KRT10, FLG, LOR, IVL, TGM1, SPINK5 and LCE1BmRNA levels in reconstructed epidermis obtained from
human keratinocytes transduced with NT shRNA or TMEM45A shRNA after 11 days of reconstruction. Bars
represent 95% confidence intervals. Paired t-test (n = 3). No statistically significant difference was observed.
(B) Immunofluorescence detection of KRT14, KRT10, IVL and FLG in reconstructed epidermis after 11 days
of reconstruction. Scale bars: 50 μm. (C) Immunofluorescence detection of KRT14, KRT10 and LOR inWT
and KOmouse adult ear skin. Scale bars: 25 μm. (B, C) The presented data are representative of the results
obtained for at least three independent experiments.
doi:10.1371/journal.pone.0147069.g006
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Fig 7. TMEM45A is not essential for the impermeability of the cornified layer. (A) Toluidine blue
exclusion assay in E16.5 and P1 of WT, KO and HETmouse littermates. (B-C) Permeability of the cornified
layer of human epidermis reconstructed from keratinocytes transduced with NT or TMEM45A shRNA to
Lucifer Yellow, tested after 7 or 11 days of reconstruction (n = 1). (B) After the incubation, the fluorescence in
medium was quantified. (C) Tissues were processed and analyzed using fluorescence microscopy. The
dotted lines delineate the polycarbonate filter (scale bars: 50 μm).
doi:10.1371/journal.pone.0147069.g007
Fig 8. TMEM45A silencing does not alter tissue localization of junctional proteins. (A)
Immunofluorescence detection of occludin (OCL) and corneodesmosin (CDSN) in RHE obtained after 11
days of reconstruction from human keratinocytes transduced with NT shRNA or TMEM45A shRNA. Scale
bars: 50 μm. (B) Immunofluorescence detection of claudin-1 (Cldn-1) in ear epidermis fromWT and KOmice.
Scale bars: 25 μm.
doi:10.1371/journal.pone.0147069.g008
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knockout animals at E16.5 and P1, meaning before and after impermeability establishing (Fig
7A). At E17.5, we observed a high variability among embryos, which could not be related to the
genotypes (S2 Fig). We concluded that skin impermeability is set up normally in the absence of
Tmem45a during mouse development.
In RHE, a functional barrier also develops progressively [17]. We assessed the permeability
of RHE at day 7 and 11 of reconstruction using the fluorescent Lucifer Yellow compound.
Amount of Lucifer Yellow (LY) in the medium and histological analysis of RHE after Lucifer
Yellow exposure showed no evidence of alteration caused by TMEM45A invalidation at both
tested stages (Fig 7B and 7C). These results revealed the effective development of the barrier in
TMEM45A-invalidated RHE.
Accordingly, the localization within the different epidermis layers of corneodesmosin
(CDSN) and occludin (OCL), two actors of the epidermal barrier, was not altered in
TMEM45A-deficient RHE (Fig 8A). Claudin-1 (Cldn-1) distribution in Tmem45a-/- mouse
epidermis was also unaffected (Fig 8B).
Finally, since the transmembrane location of TMEM45A makes it a possible proton-trans-
porter, eventually contributing to acidification of the cornified layer, the pH value at the top of
RHE was compared between tissues expressing or not TMEM45A. Again, we observed no dif-
ference (Fig 9).
In conclusion, invalidation of TMEM45A does not alter epidermal barrier formation and
function, both in mice and in humans.
Discussion
Because a strong correlation between TMEM45A expression and keratinization was previously
observed, we hypothesized that this protein could be involved in this process [4]. We tested
this hypothesis using human and mouse loss-of-function models: monolayer cultures of
human keratinocytes, RHE and knockout mouse. Our observations clearly show that
TMEM45A is dispensable for normal keratinocyte differentiation, epidermal development and
maintenance. However, we cannot conclude that TMEM45A is not implicated in these pro-
cesses. Indeed, mice knockout for different proteins, were shown to display functional alter-
ations only under challenging conditions, or when other genes/proteins were simultaneously
invalidated, pointing out to the phenomenon of biological robustness. In the case of the epider-
mis, challenging conditions could be exposure to UV-B or chemicals, injury or microbial infec-
tion. Epidermal response to such stresses in absence of TMEM45A will be analyzed in future
experiments.
Of interest, TMEM45A has already been recognized as highly expressed in skin in other
studies. For instance, its expression was ranked as 32nd among the 100 skin-associated most
expressed genes identified in silico, an observation confirmed by RT-qPCR analysis, as well as
by immune detection of the encoded protein [6]. Despite its high expression in skin, mostly in
keratinocytes and to a lesser extent in fibroblasts and endothelial cells, TMEM45A has been yet
presented as a gene with unknown cutaneous function [6]. Whereas the expression of
TMEM45A is poorly affected by inflammatory cytokines, it is upregulated in two pathological
situations: psoriasis and actinic keratosis, both characterized by an abnormal and incomplete
keratinization [6]. As TMEM45A is expressed in these poorly differentiated pathological kera-
tinocytes, it must fulfill a function still present in these abnormal keratinocytes.
The consequences of TMEM45A deficiency could be masked by (over)expression of other
genes, such as its paralog TMEM45B. This was demonstrated in many other cases of experi-
mental gene invalidation including in loricrin knockout mice that show elevated levels of small
TMEM45A in Epidermal Physiology
PLOS ONE | DOI:10.1371/journal.pone.0147069 January 19, 2016 12 / 15
prolin-rich proteins that constitute alternative precursors of the cornified envelope [21]. Such
compensatory proteins remain to be identified in the case of TMEM45A.
The localization of TMEM45A in the trans-golgi/TGN of granular keratinocytes suggests a
possible role for this protein. The two well-known functions of the trans-golgi/TGN are the
glycosylation/sulfation of proteins, and the sorting of cargoes for correct trafficking.
TMEM45A could be involved in enzymatic processes, including the maturation of lipids spe-
cific of the granular keratinocytes. In challenging conditions, TMEM45A could be implicated
in the induced secretion of pro-inflammatory cytokines such as TNF-α or in the release of
vesicular ATP [22].
In conclusion, although the previously reported strong correlation between TMEM45A
expression and keratinization, the mouse and human loss of function models used in this study
did not unveil a function for TMEM45A in epidermal morphogenesis, keratinization or barrier
formation. The role of TMEM45A in epidermal granular layer remains thus to be elucidated.
Supporting Information
S1 Fig. Immunodetection of TMEM45A in MEFs.MEFs have been incubated 16 hours under
normoxia or hypoxia (1% O2), fixed and immunolabelled for TMEM45A (green). The nuclei
were stained with Hoechst (blue). Scale bars: 50 μm.
(TIF)
S2 Fig. High variability of toluidine blue permeability in E17.5 mouse embryos. Pictures
illustrate wild type (WT), knockout (KO) and heterozygous (HET) mouse littermates. Scale
bars: 50 μm.
(TIF)
S1 File. Supplementary material and methods.
(PDF)
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